Literature DB >> 21068215

Influence of insertion site of the avian influenza virus haemagglutinin (HA) gene within the Newcastle disease virus genome on HA expression.

Kristina Ramp1, Martin Skiba, Axel Karger, Thomas C Mettenleiter, Angela Römer-Oberdörfer.   

Abstract

Members of the order Mononegavirales express their genes in a transcription gradient from 3' to 5'. To assess how this impacts on expression of a foreign transgene, the haemagglutinin (HA) of highly pathogenic avian influenza virus (HPAIV) A/chicken/Vietnam/P41/05 (subtype H5N1) was inserted between the phosphoprotein (P) and matrix protein (M), M and fusion protein (F), or F and haemagglutinin-neuraminidase protein (HN) genes of attenuated Newcastle disease virus (NDV) Clone 30. In addition, the gene encoding the neuraminidase of HPAIV A/duck/Vietnam/TG24-01/05 (subtype H5N1) was inserted into the NDV genome either alone or in combination with the HA gene. All recombinants replicated well in embryonated chicken eggs. The expression levels of HA-specific mRNA and protein were quantified by Northern blot analysis and mass spectrometry, with good correlation. HA expression levels differed only moderately and were highest in the recombinant carrying the HA insertion between the F and HN genes of NDV.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21068215     DOI: 10.1099/vir.0.027268-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  2 in total

1.  Chimeric newcastle disease virus protects chickens against avian influenza in the presence of maternally derived NDV immunity.

Authors:  Constanze Steglich; Christian Grund; Kristina Ramp; Angele Breithaupt; Dirk Höper; Günther Keil; Jutta Veits; Mario Ziller; Harald Granzow; Thomas C Mettenleiter; Angela Römer-Oberdörfer
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

Review 2.  Innovation in Newcastle Disease Virus Vectored Avian Influenza Vaccines.

Authors:  Shin-Hee Kim; Siba K Samal
Journal:  Viruses       Date:  2019-03-26       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.